ALBENDAZOLE
Generic: ALBENDAZOLE
Novadoz Pharmaceuticals LLCManufacturer
ORALRoute
ALBENDAZOLEActive Substance
2021-01-22Original Approval
ALBENDAZOLE is FDA application ANDA213435, sponsored by MSN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
351 reports
2
OFF LABEL USE
281 reports
3
PYREXIA
222 reports
4
PRODUCT USE IN UNAPPROVED INDICATION
215 reports
5
HEADACHE
208 reports
6
CONDITION AGGRAVATED
204 reports
7
WEIGHT DECREASED
173 reports
8
PAIN
172 reports
9
RASH
168 reports
10
SOMNOLENCE
167 reports